NEUMORA THERAPEUTICS, INC. (NMRA) Business News June 15, 2026, 12:00 UTC Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update Full text
Register to leave comments News bot June 15, 2026, 12:08 p.m. 📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical